Abstract
Sepsis is the most common cause of death among critically ill patients. The mortality will increase significantly if sepsis patients combine with acute kidney injury. However, the mechanism of sepsis development remains unclear nowadays. Both domestic and international researches on the sepsis management showed that continuous renal replacement therapy (CRRT), also known as continuous blood purification (CBP), plays a significant role in the treatment of sepsis. CRRT can improve the patients′ internal environment and immune homeostasis, inhibit a series of fundamental pathophysiological disorders, and increase the success rate of therapy. We will talk about the clinical efficacy and research progress of CRRT/CBP in patients with sepsis combined with AKI in this review. Key words: Sepsis; Acute kidney injury; Continuous renal replacement therapy; Continuous blood purification
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
